XXXX : a clinical study of 238 cases.

@entity1 @entity5 @entity2615 @entity3620 @entity1355
@entity3620 is a diffuse @entity5 arising in the pleura, peritoneum, or other serosal surface and is closely associated with @entity1355 exposure. An estimated 2,500 to 3,000 cases are diagnosed each year in the United States. Although there are individual case reports and small series detailing the clinical aspects of @entity2615 , few studies examine a large series of @entity1 with @entity3620 from the clinical perspective. This study reports on the findings of 238 cases of @entity3620 from a private consultative medical practice. Most cases had a history of occupational @entity1355 exposure. The mean latency was 48.5 yr, with @entity1 having a longer latency than @entity1 . The mean age at diagnosis was 70. Survival overall was poor (mean 8.8 months), but treatment was beneficial (mean 11.3 versus 6.4 months). Epithelioid histology conferred a survival advantage over sarcomatoid and responded better to treatment. Our data support an inverse relationship between @entity1355 dose and latency.
